A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule

Authors:
  • ABAna Barroso
    Ana Barroso
  • SCSara Conde
    Sara Conde
  • TGT[Acirc ]Nia Guimar[Atilde]Es
    T[Acirc ]Nia Guimar[Atilde]Es
  • JSJorge Seada
    Jorge Seada

Abstract
No abstract available